COL1A1 and idiopathic pulmonary fibrosis: While rhBMP2 treatment was sufficient to phosphorylate PPARγ and induce lipogenic marker expression in primary human IPF lung fibroblasts, rhBMP2 treatment did not result in COL1A1 downregulation.